News

PhD student writing new circuit solutions

on August 7, 2015

Maybe you remember fumbling with the wires while building a circuit board in a high school science class. If you do, you likely remember it being an arduous and time-consuming task, figuring out what went wrong if the circuit wasn’t working.

Tengyuan Zhang hopes his latest project will not only make this classroom experience more fun for students, but also instil in them the kind of scientific spark he found and continues to enjoy.

Read more
ecommPhD student writing new circuit solutions

Novare Pharmaceuticals Announces the Issuance of a U.S. patent for its RHAMM-Binding Peptides

on July 30, 2015

The patent covers the composition of RHAMM-Binding peptides as well as the use of peptides for diagnosing, and determining the prognosis for, cancer patients. The issuance of this patent is a significant milestone for Novare, which has an exclusive license to the patented technology.

Novare Pharmaceuticals today announced that the U.S. Patent and Trademark Office issued patent #9,090,659, with claims covering the composition-of-matter and use of RHAMM-binding peptides with a wide range of potential therapeutic uses. The patent also has claims for the diagnosis and prognosis of cancer, and for prescribing a course of treatment for the diagnosed cancer.

Read more
ecommNovare Pharmaceuticals Announces the Issuance of a U.S. patent for its RHAMM-Binding Peptides

Yabao Pharmaceuticals Announces Exclusive China Partnership With Lawson Health Research Institute

on July 27, 2015

Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351), a leading pharmaceutical company in China, today announced that it entered into an exclusive license with Lawson Health Research Institute (Lawson) to discover, develop and commercialize products based on annexin A5 for the treatment of sepsis in July 2014, and that by this month it has successfully completed discovery validation work and moved the program into preclinical development. The use of annexin A5 to treat sepsis was discovered by a team led by Dr. Qingping Feng, a scientist at Lawson and Western University.

Read more
ecommYabao Pharmaceuticals Announces Exclusive China Partnership With Lawson Health Research Institute

Innovators’ summer camp comes to London for week

on June 3, 2015

Kids who dream about becoming the next famous inventor, take note: a summer camp with a mission to inspire creativity and innovation in youth is coming to London.

Future Design School, a Toronto agency, is teaming up with Western’s Ivey Business School and TechAlliance to run an entrepreneurship camp in July.

“Entrepreneurship is something we should encourage in kids,” said Sarah Prevette, the founder of Future Design School who is originally from London.

Read more
ecommInnovators’ summer camp comes to London for week

Novare Announces Research Agreement with Lawson Health Research Institute

on May 21, 2015

Novare Pharmaceuticals, which is developing therapeutic products that modulate the Receptor for Hyaluronan-Mediated Motility (RHAMM), is pleased to announce a research and licensing agreement with Lawson Health Research Institute that includes the creation of an incubator focused on potential treatments for major diseases, including arthritis, breast cancer, and lung fibrosis.

Read more
ecommNovare Announces Research Agreement with Lawson Health Research Institute

Our New Look

on May 4, 2015

WORLDiscoveries® is thrilled to introduce our completely enhanced and user-friendly website that has been redesigned to highlight our accomplishments and showcase our startups and digital innovations. After extensive research on user preference regarding online navigation, we have designed a platform that is easy to use and provides all the necessary information sought by customers, innovators and researchers. Equipped with high quality graphics for an enhanced visual experience and designed with functionality across platforms, our website ensures optimal user experience while gaining full insight into our company online.

Read more
ecommOur New Look

“I made that.” “So did I.”

on May 4, 2015

3D printing is the next great hope… depending who you ask.

Additive manufacturing or “3D printing” is a technology that allows for the creation of objects (both new or “copies” of existing objects) from a digital 3D blueprint and a substrate that can be successively deposited in layers. It is almost certainly a transformative technology that may disrupt current paradigms in a number of sectors. One very thorny issue that companies, governments and lawyers are facing is the interplay between intellectual property (IP) rights and replication. The current rise in the availability of consumer 3D printers makes it easy for virtually anyone to make potentially illegal copies of protected goods. Is it possible to support this technology yet protect the IP rights of inventors, designers, artists and companies?

Read more
ecomm“I made that.” “So did I.”

Interprofessional Education Just Got More Fun

on April 20, 2015

There is a critical need for healthcare providers to enhance collaborative interprofessional team skills and Dr. Carole Orchard from Western University has created a fun and exciting way to improve these skills.

Circles of Care is an innovative interprofessional education (IPE) online game designed to help healthcare providers gain skills working in collaborative interprofessional teams. The game contains twelve patient/client cases from a variety of practice areas and the teams can play as many times as they wish.

Read more
ecommInterprofessional Education Just Got More Fun

Robarts Clinical Trials Inc. moving into the Bell building on Dundas St. in London

on April 8, 2015

Downtown London will soon be boosted by about 100 bright young minds with the movement of Robarts Clinical Trials Inc. into the Bell building at 100 Dundas St.

“Robarts attracts the best researchers from around the world. Now they will work in our downtown and can live in our downtown,” said Mayor Matt Brown.

The move will also allow the prestigious medical facility to expand.

“This will allow us to do better science, bigger science, science that makes a difference,” said Brian Feagan, CEO of Robarts Clinical Trials.

Read more
ecommRobarts Clinical Trials Inc. moving into the Bell building on Dundas St. in London